Cargando…

Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat

BACKGROUND: Physicians consider ease of use, satisfaction, and preferences when prescribing an inhaler device. These factors may impact appropriate usage and compliance. METHODS: The objectives were to quantify the relative importance of inhaler attributes in patients currently using Combivent Respi...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Kimberly H., Su, Jun, González, Juan Marcos, Trudeau, Jeremiah J., Nelson, Lauren M., Hauber, Brett, Hollis, Kelly A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644105/
https://www.ncbi.nlm.nih.gov/pubmed/29037248
http://dx.doi.org/10.1186/s12955-017-0780-z
_version_ 1783271666021826560
author Davis, Kimberly H.
Su, Jun
González, Juan Marcos
Trudeau, Jeremiah J.
Nelson, Lauren M.
Hauber, Brett
Hollis, Kelly A.
author_facet Davis, Kimberly H.
Su, Jun
González, Juan Marcos
Trudeau, Jeremiah J.
Nelson, Lauren M.
Hauber, Brett
Hollis, Kelly A.
author_sort Davis, Kimberly H.
collection PubMed
description BACKGROUND: Physicians consider ease of use, satisfaction, and preferences when prescribing an inhaler device. These factors may impact appropriate usage and compliance. METHODS: The objectives were to quantify the relative importance of inhaler attributes in patients currently using Combivent Respimat by eliciting preferences for performance and convenience attributes assessed by items in the Patient Satisfaction and Preference Questionnaire (PASAPQ). Using a pharmacy database, 19,964 adults in the United States who filled ≥2 Combivent Respimat prescriptions were identified. Of those, 8150 patients were randomly selected to receive invitation letters. The online cross-sectional survey included the PASAPQ and best-worst scaling (BWS) questions. The PASAPQ measures satisfaction with medication attributes across two domains: performance and convenience. BWS questions asked participants to select the most and least important device attributes. A descriptive statistics analysis of the PASAPQ and a random-parameters logit model of BWS responses were conducted. RESULTS: The survey was completed by 503 participants. Most were female (57.3%), white (88.5%), and 51–70 years old (67.6%). Approximately 47% reported a chronic obstructive pulmonary disease diagnosis, 21.9% asthma, 8.2% other lung disease, and 23.1% more than one lung disease. PASAPQ scores indicated that the majority were satisfied or very satisfied; up to 20% reported being dissatisfied with Combivent Respimat. The three most important inhaler attributes were Feeling that your medicine gets into your lungs, Inhaler works reliably, and Inhaler makes inhaling your medicine easy. The most important attributes corresponded to six of seven items in the PASAPQ performance domain. CONCLUSIONS: Most participants reported satisfaction with Combivent Respimat. Performance attributes were more important than convenience attributes.
format Online
Article
Text
id pubmed-5644105
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56441052017-10-26 Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat Davis, Kimberly H. Su, Jun González, Juan Marcos Trudeau, Jeremiah J. Nelson, Lauren M. Hauber, Brett Hollis, Kelly A. Health Qual Life Outcomes Research BACKGROUND: Physicians consider ease of use, satisfaction, and preferences when prescribing an inhaler device. These factors may impact appropriate usage and compliance. METHODS: The objectives were to quantify the relative importance of inhaler attributes in patients currently using Combivent Respimat by eliciting preferences for performance and convenience attributes assessed by items in the Patient Satisfaction and Preference Questionnaire (PASAPQ). Using a pharmacy database, 19,964 adults in the United States who filled ≥2 Combivent Respimat prescriptions were identified. Of those, 8150 patients were randomly selected to receive invitation letters. The online cross-sectional survey included the PASAPQ and best-worst scaling (BWS) questions. The PASAPQ measures satisfaction with medication attributes across two domains: performance and convenience. BWS questions asked participants to select the most and least important device attributes. A descriptive statistics analysis of the PASAPQ and a random-parameters logit model of BWS responses were conducted. RESULTS: The survey was completed by 503 participants. Most were female (57.3%), white (88.5%), and 51–70 years old (67.6%). Approximately 47% reported a chronic obstructive pulmonary disease diagnosis, 21.9% asthma, 8.2% other lung disease, and 23.1% more than one lung disease. PASAPQ scores indicated that the majority were satisfied or very satisfied; up to 20% reported being dissatisfied with Combivent Respimat. The three most important inhaler attributes were Feeling that your medicine gets into your lungs, Inhaler works reliably, and Inhaler makes inhaling your medicine easy. The most important attributes corresponded to six of seven items in the PASAPQ performance domain. CONCLUSIONS: Most participants reported satisfaction with Combivent Respimat. Performance attributes were more important than convenience attributes. BioMed Central 2017-10-16 /pmc/articles/PMC5644105/ /pubmed/29037248 http://dx.doi.org/10.1186/s12955-017-0780-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Davis, Kimberly H.
Su, Jun
González, Juan Marcos
Trudeau, Jeremiah J.
Nelson, Lauren M.
Hauber, Brett
Hollis, Kelly A.
Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat
title Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat
title_full Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat
title_fullStr Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat
title_full_unstemmed Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat
title_short Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat
title_sort quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using combivent respimat
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644105/
https://www.ncbi.nlm.nih.gov/pubmed/29037248
http://dx.doi.org/10.1186/s12955-017-0780-z
work_keys_str_mv AT daviskimberlyh quantifyingtheimportanceofinhalerattributescorrespondingtoitemsinthepatientsatisfactionandpreferencequestionnaireinpatientsusingcombiventrespimat
AT sujun quantifyingtheimportanceofinhalerattributescorrespondingtoitemsinthepatientsatisfactionandpreferencequestionnaireinpatientsusingcombiventrespimat
AT gonzalezjuanmarcos quantifyingtheimportanceofinhalerattributescorrespondingtoitemsinthepatientsatisfactionandpreferencequestionnaireinpatientsusingcombiventrespimat
AT trudeaujeremiahj quantifyingtheimportanceofinhalerattributescorrespondingtoitemsinthepatientsatisfactionandpreferencequestionnaireinpatientsusingcombiventrespimat
AT nelsonlaurenm quantifyingtheimportanceofinhalerattributescorrespondingtoitemsinthepatientsatisfactionandpreferencequestionnaireinpatientsusingcombiventrespimat
AT hauberbrett quantifyingtheimportanceofinhalerattributescorrespondingtoitemsinthepatientsatisfactionandpreferencequestionnaireinpatientsusingcombiventrespimat
AT holliskellya quantifyingtheimportanceofinhalerattributescorrespondingtoitemsinthepatientsatisfactionandpreferencequestionnaireinpatientsusingcombiventrespimat